MED15 acts as an oncogene in numerous types of cancer, including hepatocellular carcinoma [39], prostate cancer [40], head and neck squamous cell carcinoma [41], bladder carcinoma [42], and renal carcinoma [22], to promote tumor progression. Here, MED15 is linked to prostate cancer.